ASEP Medical Holdings Inc. (CSE:ASEP)
Canada · Delayed Price · Currency is CAD 0.5000
0.00 (0.00%)
May 5, 2025, 2:56 PM EST
ASEP Medical Holdings Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| 0.3 | 0.3 | 0.02 | - | - | - | Upgrade | |
Revenue Growth (YoY) | 21.67% | 1307.69% | - | - | - | - | Upgrade |
Cost of Revenue | - | - | - | - | - | 0.03 | Upgrade |
Gross Profit | 0.3 | 0.3 | 0.02 | - | - | -0.03 | Upgrade |
Selling, General & Admin | 1.9 | 2.15 | 2.71 | 1.58 | 0.79 | 0 | Upgrade |
Research & Development | 0.03 | 0.08 | 0.68 | 0.62 | 0.08 | - | Upgrade |
Amortization of Goodwill & Intangibles | 0.85 | 1.3 | 1.29 | 1.28 | 0.19 | - | Upgrade |
Operating Expenses | 2.78 | 3.96 | 6.63 | 4.6 | 2.11 | 0 | Upgrade |
Operating Income | -2.48 | -3.66 | -6.61 | -4.6 | -2.11 | -0.03 | Upgrade |
Interest Expense | -0.01 | -0 | -0 | -0 | -0.11 | - | Upgrade |
Earnings From Equity Investments | - | -0.18 | - | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | -0.02 | -0.01 | -0 | -0 | -0 | - | Upgrade |
Other Non Operating Income (Expenses) | -0.17 | -0.23 | -1.11 | -0.85 | -0.34 | - | Upgrade |
EBT Excluding Unusual Items | -2.68 | -4.09 | -7.73 | -5.45 | -2.56 | -0.03 | Upgrade |
Merger & Restructuring Charges | - | - | -1.28 | -0.4 | - | - | Upgrade |
Gain (Loss) on Sale of Investments | 0.22 | 0.27 | - | - | - | - | Upgrade |
Asset Writedown | -9.88 | -9.88 | - | - | - | - | Upgrade |
Other Unusual Items | -0.54 | - | -0.43 | - | - | - | Upgrade |
Pretax Income | -12.88 | -13.7 | -9.43 | -5.85 | -2.56 | -0.03 | Upgrade |
Income Tax Expense | - | - | - | -0.09 | - | - | Upgrade |
Earnings From Continuing Operations | -12.88 | -13.7 | -9.43 | -5.76 | -2.56 | -0.03 | Upgrade |
Minority Interest in Earnings | 5.04 | 5.43 | 1.2 | 1.23 | 0.16 | - | Upgrade |
Net Income | -7.84 | -8.27 | -8.23 | -4.52 | -2.4 | -0.03 | Upgrade |
Net Income to Common | -7.84 | -8.27 | -8.23 | -4.52 | -2.4 | -0.03 | Upgrade |
Shares Outstanding (Basic) | 9 | 8 | 6 | 6 | 2 | - | Upgrade |
Shares Outstanding (Diluted) | 9 | 8 | 6 | 6 | 2 | - | Upgrade |
Shares Change (YoY) | 28.42% | 22.16% | 10.75% | 163.12% | - | - | Upgrade |
EPS (Basic) | -0.83 | -1.09 | -1.32 | -0.81 | -1.12 | - | Upgrade |
EPS (Diluted) | -0.83 | -1.09 | -1.32 | -0.81 | -1.12 | - | Upgrade |
Free Cash Flow | -0.87 | -0.34 | -2.71 | -3.61 | -1.37 | -0.02 | Upgrade |
Free Cash Flow Per Share | -0.09 | -0.04 | -0.44 | -0.64 | -0.64 | - | Upgrade |
Gross Margin | 100.00% | 100.00% | 100.00% | - | - | - | Upgrade |
Operating Margin | -837.25% | -1229.41% | -31271.78% | - | - | - | Upgrade |
Profit Margin | -2640.56% | -2779.83% | -38918.30% | - | - | - | Upgrade |
Free Cash Flow Margin | -294.72% | -113.29% | -12837.39% | - | - | - | Upgrade |
EBITDA | -1.65 | -2.37 | -5.33 | -3.33 | -1.92 | - | Upgrade |
D&A For EBITDA | 0.84 | 1.29 | 1.28 | 1.27 | 0.19 | - | Upgrade |
EBIT | -2.48 | -3.66 | -6.61 | -4.6 | -2.11 | -0.03 | Upgrade |
Revenue as Reported | 0.3 | 0.3 | 0.02 | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.